Crossmark

Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy

Published Online: 2024-03-11

Authors

Ito, Yusuke

Inoue, Satoshi

Kagoya, Yuki https://orcid.org/0000-0002-6216-6730
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP23bm0704066)

Japan Agency for Medical Research and Development (JP23ym0126072)

Japan Agency for Medical Research and Development (JP23ama221303)

Japan Society for the Promotion of Science (23H02779)

Fusion Oriented REsearch for disruptive Science and Technology (JPMJFR2060)
License Information

Text and Data Mining valid from 2024-03-11

Version of Record valid from 2024-03-11
More Information

Article History

Received: 5 January 2024

Accepted: 21 February 2024

First Online: 11 March 2024

Declarations

:

: Not applicable.

: Not applicable.

: Y. Kagoya received a commercial research grant from Takara Bio. The other authors declare that they have no competing interests.

Document is current